Based on the antagonistic impact on the risk of breast cancer, some authors have proposed that the adiponectin/leptin ratio may be more useful than the individual levels of adipokines for assessing the risk profile of breast cancer (25). The gene discussed is ADIPOQ; the disease is breast cancer.